Featured News
More News
Breakthrough Study led by SDRC Investigator Katrin Svensson Identifies Ozempic Rival For Weight Loss Without The Side Effects
Using an AI-based algorithm, Katrin Svensson, PhD, and lead researcher Laetitia Coassolo, PhD, identified a 12-amino acid peptide that suppresses appetite and promotes weight loss in mice and minipigs by activating different metabolic and neuronal pathways than GLP-1.
SDRC Investigator Natalie Torok Unveils New Insights on Liver Cancer Risk in Type 2 Diabetes Patients
A Stanford Medicine study led by Natalie Torok suggests revised screening guidelines, highlighting viscoelasticity as a key biophysical marker for liver cancer in diabetics, challenging traditional approaches to diagnosis.
SDRC Investigators Michael Snyder and Tracey McLaughlin Harness AI to Predict and Identify Type 2 Diabetes Subtypes Using Simple Glucose Monitors
New AI-powered algorithm offers a more accurate, accessible method for diagnosing diabetes subtypes and tailoring treatments, with potential for widespread impact.
Breakthrough Study by SDRC Investigator Jonathan Long Uncovers the Connection Between PTER and Taurine Metabolism in the Fight Against Obesity
Jonathan Long's team has uncovered a link between PTER and taurine metabolism in mice, revealing its potential to combat weight gain and metabolic disorders thus paving the way for innovative anti-obesity drugs through a novel GLP1R-independent pathway.
Using an AI-based algorithm, Katrin Svensson, PhD, and lead researcher Laetitia Coassolo, PhD, identified a 12-amino acid peptide that suppresses appetite and promotes weight loss in mice and minipigs by activating different metabolic and neuronal pathways than GLP-1.